← Home · All topics

Blood Cancer

2 GoKawiil briefs on this topic

Genmab Shares Rise Following Positive Blood-Cancer Treatment Data

Genmab announced that its collaboration with AbbVie demonstrated that their drug Epkinly increased survival time for patients with a prevalent form of lymphoma. The results were presented in a recent study, prompting a surge in Genmab's stock price. The findings suggest potential for expanded use of the medication in blood cancer therapies.

wsj.com · 2026-10-06

CAR T Pioneer Renier Brentjens Develops Next-Gen Cell Therapies for Solid Tumors

Renier Brentjens, one of the early researchers behind CAR T cell therapy, is now developing a new generation of engineered 'living drug' treatments. His current work aims to extend the success these therapies have had against blood cancers to solid tumors, which have proven far harder to treat with cell-based approaches.

gizmodo.com · 2026-09-26